Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak’s Takeover Bid Valued Up To $7.75/Share On Wednesday, Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) confirmed that, since March 2024, it had received several unsolicited proposals from Future Pak LLC to acquire all of Vanda’s outstanding shares. The most recent proposal offered $7.25 – $7.75 per share, subject to certain terms and conditions. The current proposal […]